We are proud to have co-organized the impactful event Biodatathon, in partnership with SRH University, Heidelberg Campus and the Biomed X Institute. This exciting hackathon, hosted on the SRH University campus, brought together skilled participants to tackle challenging tasks in drug research using the latest AI and data science techniques.
The Challenge: Revolutionizing Drug Development
Drug development is a monumental task. On average, it takes 14 years to develop a new drug, with an estimated 90% failure rate. These figures highlight the immense complexity, time, and resources required for successful pharmaceutical innovation. At Neuron Solutions, we understand these challenges firsthand, having collaborated with international pharmaceutical company Gedeon Richter plc to implement AI-based advanced analytics in pharmaceutical research. Read more about our earlier collaboration.
Purpose and Objectives of Biodatathon
The Biodatathon was designed to explore how cutting-edge AI solutions can:
- Achieve state-of-the-art performance in question-and-answer benchmarks over biomedical knowledge graphs.
- Enhance understanding of how multi-modal embeddings can improve answer retrieval.
- Demonstrate the potential of integrating these advancements into an AI Agentic framework, complete with tool access and a chatbot UI front-end, to boost productivity in working with biomedical knowledge graphs.
These goals are in line with current research efforts by Biomed X and broadly reflect the pharmaceutical industry’s focus on applying AI to drug research challenges.
Collaborative Effort
The event was a true collaborative effort:
- SRH University, Heidelberg Campus: Hosted the hackathon and provided a vibrant academic environment. The main representative from the university was Prof. Dr. Swati Chandna, who leads the university’s Applied Data Science and Analytics (ADSA) and Big Data and Business Analytics (BDBA) programs. She was actually the originator of the idea for this hackathon.
- Biomed X Institute: Designed the challenging problem statement, encouraging participants to push the boundaries of AI in drug research. Douglas McCloskey, leading together with his team and partner Sanofi the development of a Next Generation Virtual Patient Engine (VPE) for Clinical Translation of Drug Candidates, along with his colleagues Gurdeep Singh, Lilija Wehling and Ahmad Wisnu Mulyadi were actively involved.
- Neuron Solutions: Provided mentorship alongside experts from the other organizing entities, guiding teams toward impactful solutions and assisted SRH University with overall organizational tasks with two of our co-founders, Lev Szabados and Otto Werschitz being present at the event.
Results: Science Meets Innovation
Three talented teams competed in the hackathon, each presenting innovative and actionable ideas. The work accomplished included multi-modal embeddings for drugs and proteins, enriching nodes that lacked features to enhance insights, and subgraph extraction along with an agentic workflow for enriching, embedding, and reranking candidate answers. Their solutions demonstrated real scientific value, and, true to the collaborative spirit of the event, their work has been open-sourced. Explore their projects on GitHub.These outcomes highlight the power of collective effort and the potential of AI to transform drug research processes.
Building Bridges in the AI Community
We at Neuron Solutions are excited to continue our collaboration with SRH University, Heidelberg Campus. Being part of the dynamic AI community in Heidelberg and working alongside forward-thinking organizations like the Biomed X Institute is an inspiring experience.
Stay tuned for more updates as we build on this momentum and work toward a future where AI transforms industries and businesses.
Are you interested in understanding how AI can improve your enteprise’s operations or how you can innovate using AI? Contact us.
